817 related articles for article (PubMed ID: 25746901)
1. Impact of the spheroid model complexity on drug response.
Hoffmann OI; Ilmberger C; Magosch S; Joka M; Jauch KW; Mayer B
J Biotechnol; 2015 Jul; 205():14-23. PubMed ID: 25746901
[TBL] [Abstract][Full Text] [Related]
2. Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.
Varesano S; Zocchi MR; Poggi A
Front Immunol; 2018; 9():998. PubMed ID: 29867975
[TBL] [Abstract][Full Text] [Related]
3. Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma.
Zoetemelk M; Rausch M; Colin DJ; Dormond O; Nowak-Sliwinska P
Sci Rep; 2019 May; 9(1):7103. PubMed ID: 31068603
[TBL] [Abstract][Full Text] [Related]
4. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic effect of 5-fluorouracil-doxorubicin combination on colorectal cancer cell monolayers and spheroids.
Bilgin S
Mol Biol Rep; 2024 May; 51(1):603. PubMed ID: 38698270
[TBL] [Abstract][Full Text] [Related]
6. Colorectal tumor cells treated with 5-FU, oxaliplatin, irinotecan, and cetuximab exhibit changes in 18F-FDG incorporation corresponding to hexokinase activity and glucose transport.
Sharma RI; Smith TA
J Nucl Med; 2008 Aug; 49(8):1386-94. PubMed ID: 18632807
[TBL] [Abstract][Full Text] [Related]
7. Impact of a Desmoplastic Tumor Microenvironment for Colon Cancer Drug Sensitivity: A Study with 3D Chimeric Tumor Spheroids.
Goudar VS; Koduri MP; Ta YN; Chen Y; Chu LA; Lu LS; Tseng FG
ACS Appl Mater Interfaces; 2021 Oct; 13(41):48478-48491. PubMed ID: 34633791
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs.
Schreiber-Brynzak E; Klapproth E; Unger C; Lichtscheidl-Schultz I; Göschl S; Schweighofer S; Trondl R; Dolznig H; Jakupec MA; Keppler BK
Invest New Drugs; 2015 Aug; 33(4):835-47. PubMed ID: 26091914
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic activity of the seaweed compound fucosterol, alone and in combination with 5-fluorouracil, in colon cells using 2D and 3D culturing.
Ramos AA; Almeida T; Lima B; Rocha E
J Toxicol Environ Health A; 2019; 82(9):537-549. PubMed ID: 31258008
[TBL] [Abstract][Full Text] [Related]
10. Identification of a potent epigenetic biomarker for resistance to camptothecin and poor outcome to irinotecan-based chemotherapy in colon cancer.
Miyaki Y; Suzuki K; Koizumi K; Kato T; Saito M; Kamiyama H; Maeda T; Shibata K; Shiya N; Konishi F
Int J Oncol; 2012 Jan; 40(1):217-26. PubMed ID: 21901246
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug development.
Ekert JE; Johnson K; Strake B; Pardinas J; Jarantow S; Perkinson R; Colter DC
PLoS One; 2014; 9(3):e92248. PubMed ID: 24638075
[TBL] [Abstract][Full Text] [Related]
12. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
Meier-Hubberten JC; Sanderson MP
Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
[TBL] [Abstract][Full Text] [Related]
13. Low dose chemotherapeutic drugs without overt cytotoxic effects decrease the secretion of VEGF by cultured human tumor cells: a tentative relationship between drug type and tumor cell type response.
Aktas SH; Akbulut H; Akgun N; Icli F
Cancer Biomark; 2012-2013; 12(3):135-40. PubMed ID: 23481572
[TBL] [Abstract][Full Text] [Related]
14. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system.
Karlsson H; Fryknäs M; Larsson R; Nygren P
Exp Cell Res; 2012 Aug; 318(13):1577-85. PubMed ID: 22487097
[TBL] [Abstract][Full Text] [Related]
15. Regorafenib as a potential adjuvant chemotherapy agent in disseminated small colon cancer: Drug selection outcome of a novel screening system using nanoimprinting 3-dimensional culture with HCT116-RFP cells.
Yoshii Y; Furukawa T; Aoyama H; Adachi N; Zhang MR; Wakizaka H; Fujibayashi Y; Saga T
Int J Oncol; 2016 Apr; 48(4):1477-84. PubMed ID: 26820693
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Size-Based Analysis of Tumor Spheroids and Responses to Therapeutics.
Thakuri PS; Gupta M; Plaster M; Tavana H
Assay Drug Dev Technol; 2019 Apr; 17(3):140-149. PubMed ID: 30958703
[TBL] [Abstract][Full Text] [Related]
17. Impact of the thyroid hormone T3 and its nuclear receptor TRα1 on colon cancer stem cell phenotypes and response to chemotherapies.
Giolito MV; Bodoirat S; La Rosa T; Reslinger M; Guardia GDA; Mourtada J; Claret L; Joung A; Galante PAF; Penalva LOF; Plateroti M
Cell Death Dis; 2024 May; 15(5):306. PubMed ID: 38693105
[TBL] [Abstract][Full Text] [Related]
18. In-depth phenotypic characterization of multicellular tumor spheroids: Effects of 5-Fluorouracil.
Virgone-Carlotta A; Lemasson M; Mertani HC; Diaz JJ; Monnier S; Dehoux T; Delanoë-Ayari H; Rivière C; Rieu JP
PLoS One; 2017; 12(11):e0188100. PubMed ID: 29141026
[TBL] [Abstract][Full Text] [Related]
19. Identification and Characterization of CD107a as a Marker of Low Reactive Oxygen Species in Chemoresistant Cells in Colorectal Cancer.
Kitahara T; Haraguchi N; Takahashi H; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
Ann Surg Oncol; 2017 Apr; 24(4):1110-1119. PubMed ID: 27834032
[TBL] [Abstract][Full Text] [Related]
20. A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery.
Shao H; Moller M; Wang D; Ting A; Boulina M; Liu ZJ
J Vis Exp; 2020 Feb; (156):. PubMed ID: 32176195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]